In the 4th quarter of 2020, German based SCHOTT AG, started up a greenfield production plant for pharmaceutical glass tubing in Zhejiang Province, People's Republic of China. The new plant will produce high-quality borosilicate glass tubing – the base material for pharmaceutical packaging such as vials, ampoules, syringes and cartridges, which the vast majority of COVID-19 vaccine projects rely upon.
EME, with the support of our daughter company Shanghai Precision, supplied the Batch Plant incl. Batch Transport and Cullet Return System on a turn-key basis, including building, process equipment and the control system. The batch plant is designed for several furnaces and different glass types.
For the process technology EME adhered to the strict SCHOTT requirements in the dosing, weighing and mixing areas in order to obtain SCHOTT's highest quality pharmaceutical glass.
21.01.2021,
Notícias sobre o material do site é copyright e pertence à empresa ou ao seu fornecedor de terceiros notícia, e todos os direitos reservados. Qualquer usuário que acessa esse material poderá fazê-lo apenas para seu próprio uso pessoal, bem como a utilização desse material é de risco exclusivo do Utilizador. A redistribuição ou exploração comercial de material tal notícia é expressamente proibida. Se tal notícia material é fornecido por um terceiro, cada utilizador concorda em observar e estar vinculado aos termos específicos de utilização aplicáveis a material notícia. Nós não representamos nem endossamos a precisão ou confiabilidade de qualquer informação contida em qualquer notícia ou sites externos referidos na notícia.
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.